🇺🇸 FDA
Patent

US 10786545

Use of peptides that block metadherin-SND1 interaction as treatment for cancer

granted A61KA61K38/08A61K38/10

Quick answer

US patent 10786545 (Use of peptides that block metadherin-SND1 interaction as treatment for cancer) held by THE TRUSTEES OF PRINCETON UNIVERSITY expires Mon Sep 24 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
THE TRUSTEES OF PRINCETON UNIVERSITY
Grant date
Tue Sep 29 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 24 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K38/08, A61K38/10, A61K38/1709, A61P